HIV and the Brain: Part 2 At the 17th Conference on Retroviruses and Opportunistic Infections (CROI) in San Francisco—David Evans speaks with Scott Letendre, MD, from the University of California in San Diego, about the relationship of HIV levels in the brain versus the blood, and what that might mean for treating HIV.
New Treatments for HIV: Part 1 At the 17th
Conference on Retroviruses and Opportunistic Infections (CROI) in San
Francisco—Tim Horn speaks with David Hardy, MD, from Cedars Sinai
Medical Center in Los Angeles, about new HIV treatments—including the
drug blood level-booster, cobicistat, and the new integrase inhibitor,
elvitegravir. Part 1 of a 2-part video.
New Treatments for HIV: Part 2 At the 17th Conference on Retroviruses and Opportunistic Infections (CROI) in San Francisco—Tim Horn speaks with David Hardy, MD, from Cedars Sinai Medical Center in Los Angeles, about new HIV treatments—including two entry inhibitors: vicriviroc and TBR-652. Part 2 of a 2-part video.
March 08, 2010
Cancer Risks and HIV At the 17th Conference on Retroviruses and Opportunistic Infections (CROI) in San Francisco—David Evans speaks with Michael Silverberg, PhD, from the Kaiser Permanente Division of Research in Oakland, California, about the latest research on cancer risk in people with HIV, and strategies for reducing the risk.
HIV/AIDS Awareness at Greenwich High School POZ Editor-in-Chief Regan Hofmann and Rep. Jim Himes (D-Conn.) talk about HIV prevention at Greenwich High School in honor of World AIDS Day. (Watch video.)
HIV and the Brain: Part 1 At the 17th Conference on
Retroviruses and Opportunistic Infections (CROI) in San Francisco—David
Evans speaks with Ronald Ellis, MD, PhD, from the University of
California in San Francisco, about factors that protect the brain from
HIV. This is the first of a two part video on HIV and the brain.
HIV Prevention: On the Verge of Success? At the 17th Conference on Retroviruses and Opportunistic Infections (CROI) in San Francisco—David Evans speaks with Mitchell Warren, from the AIDS Vaccine Advocacy Coalition in New York City, about the state of prevention research, which could be on the verge of new successes with PrEP and test-and-treat strategies.
HIV Treatment in Southern Africa At the 17th Conference on Retroviruses and Opportunistic Infections (CROI) in San Francisco—David Evans speaks with Suzanne Ingle, from the University of Bristol in England, about factors affecting the roll out of HIV treatment in Southern Africa.
March 01, 2010
Women and Advocacy Angela Green, executive director of the Iris Center in San Francisco, talks about women and advocacy. (Watch video.)
HIV and Bone Health At the 17th
Conference on Retroviruses and Opportunistic Infections (CROI) in San
Francisco, David Evans speaks with Grace McComsey, MD—division chief of
Pediatric Infectious Disease and Rheumatology at Case Western Reserve
University in Cleveland—about the causes of bone loss in people living
with HIV, and what can be done about it.
March 09, 2010
At the 17th Conference on Retroviruses and Opportunistic Infections (CROI) in San Francisco—David Evans speaks with Scott Letendre, MD, from the University of California in San Diego, about the relationship of HIV levels in the brain versus the blood, and what that might mean for treating HIV.
At the 17th
Conference on Retroviruses and Opportunistic Infections (CROI) in San
Francisco—Tim Horn speaks with David Hardy, MD, from Cedars Sinai
Medical Center in Los Angeles, about new HIV treatments—including the
drug blood level-booster, cobicistat, and the new integrase inhibitor,
elvitegravir. Part 1 of a 2-part video.
At the 17th Conference on Retroviruses and Opportunistic Infections (CROI) in San Francisco—Tim Horn speaks with David Hardy, MD, from Cedars Sinai Medical Center in Los Angeles, about new HIV treatments—including two entry inhibitors: vicriviroc and TBR-652. Part 2 of a 2-part video.
At the 17th Conference on Retroviruses and Opportunistic Infections (CROI) in San Francisco—David Evans speaks with Michael Silverberg, PhD, from the Kaiser Permanente Division of Research in Oakland, California, about the latest research on cancer risk in people with HIV, and strategies for reducing the risk.
POZ Editor-in-Chief Regan Hofmann and Rep. Jim Himes (D-Conn.) talk about HIV prevention at Greenwich High School in honor of World AIDS Day. (Watch video.)
At the 17th Conference on
Retroviruses and Opportunistic Infections (CROI) in San Francisco—David
Evans speaks with Ronald Ellis, MD, PhD, from the University of
California in San Francisco, about factors that protect the brain from
HIV. This is the first of a two part video on HIV and the brain.
At the 17th Conference on Retroviruses and Opportunistic Infections (CROI) in San Francisco—David Evans speaks with Mitchell Warren, from the AIDS Vaccine Advocacy Coalition in New York City, about the state of prevention research, which could be on the verge of new successes with PrEP and test-and-treat strategies.
At the 17th Conference on Retroviruses and Opportunistic Infections (CROI) in San Francisco—David Evans speaks with Suzanne Ingle, from the University of Bristol in England, about factors affecting the roll out of HIV treatment in Southern Africa.
Angela Green, executive director of the Iris Center in San Francisco, talks about women and advocacy. (Watch video.)
At the 17th
Conference on Retroviruses and Opportunistic Infections (CROI) in San
Francisco, David Evans speaks with Grace McComsey, MD—division chief of
Pediatric Infectious Disease and Rheumatology at Case Western Reserve
University in Cleveland—about the causes of bone loss in people living
with HIV, and what can be done about it.
